HomeAbbvie raises sales outlook of two immunology drugs to more than $17.5 billion in 2025A sign stands outside a Abbvie facility in Cambridge

A sign stands outside a Abbvie facility in Cambridge

A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder

Most Read

Apple’s new fees for app developers under fresh EU scrutiny, Bloomberg reports

January 13, 2025

Factbox-LA blaze damage likely to be largest wildfire insured loss in US history

January 13, 2025

Eli Lilly to buy Scorpion Therapeutics’ cancer therapy for up to $2.5 billion

January 13, 2025

Cleveland-Cliffs partners with Nucor to potentially bid for US Steel, CNBC reports

January 13, 2025